Tag: FDA generic drug surveillance

Post-Market Surveillance: How the FDA Monitors Generic Drugs After Approval
Medications

Post-Market Surveillance: How the FDA Monitors Generic Drugs After Approval

The FDA doesn't stop monitoring generic drugs after approval. Using FAERS, Sentinel, and AI tools, they track safety, catch hidden risks, and act when problems arise-ensuring millions of daily users stay protected.

  • Dec, 5 2025
  • 0

Recent Post

Why Cheaper Drugs Feel Less Effective: The Psychology Behind Price and Perceived Pain Relief

Why Cheaper Drugs Feel Less Effective: The Psychology Behind Price and Perceived Pain Relief

Dec, 2 2025
Generic Price Transparency: Tools to Find the Best Price for Prescription Medications

Generic Price Transparency: Tools to Find the Best Price for Prescription Medications

Dec, 2 2025
How to Read FDA Safety Communications for Your Medications

How to Read FDA Safety Communications for Your Medications

Dec, 1 2025
Annual Savings from FDA Generic Drug Approvals: Year-by-Year Breakdown

Annual Savings from FDA Generic Drug Approvals: Year-by-Year Breakdown

Dec, 4 2025
Post-Market Surveillance: How the FDA Monitors Generic Drugs After Approval

Post-Market Surveillance: How the FDA Monitors Generic Drugs After Approval

Dec, 5 2025

Categories